Your browser doesn't support javascript.
loading
Individual Meropenem Clearance in Infants on ECMO and CVVHDF is Difficult to Predict: A Case Report and Review of the Literature.
Jabareen, Ali; Nassar, Laila; Karasik, Marina; Efrati, Edna; Hadash, Amir; Kassis, Imad; Kurnik, Daniel.
Afiliação
  • Jabareen A; From the Pharmacy Services, Rambam Health Care Campus, Haifa, Israel.
  • Nassar L; Clinical Pharmacology Unit, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, Haifa, Israel.
  • Karasik M; Clinical Pharmacology Unit, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, Haifa, Israel.
  • Efrati E; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Hadash A; Toxicology and Pharmacology Laboratory, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, Haifa, Israel.
  • Kassis I; Toxicology and Pharmacology Laboratory, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, Haifa, Israel.
  • Kurnik D; Pediatric Intensive Care Unit, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Pediatr Infect Dis J ; 41(2): 117-120, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34966143

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea / Meropeném / Terapia de Substituição Renal Contínua / Antibacterianos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxigenação por Membrana Extracorpórea / Meropeném / Terapia de Substituição Renal Contínua / Antibacterianos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article